| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |